Login / Signup

Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: 4-year results from the expanded access program.

Jerzy P SzaflarskiOrrin DevinskyMerrick LopezYong D ParkPilar Pichon ZentilAnup D PatelElizabeth A ThieleRobert T WechslerDaniel CheckettsFarhad Sahebkar
Published in: Epilepsia (2022)
Add-on CBD was associated with sustained seizure reduction up to 192 weeks with an acceptable safety profile and can be used for long-term treatment of TREs.
Keyphrases
  • quality improvement
  • replacement therapy
  • temporal lobe epilepsy
  • smoking cessation